Skip to main content

Find Clinical Trials

Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

47 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies

NCT00038051

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +19 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders

NCT00873574

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Department of Hematology, Hospital Saint Antoine Paris, France

View Trial Details

Completed

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

NCT00186342

Conditions: Acute Disease, Blood and Marrow Transplant (BMT), Bone Marrow Diseases, +15 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

NCT00787761

Conditions: Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
Locations: Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

View Trial Details

Completed

Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood

NCT00146055

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +21 more
Locations: The University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis

NCT00745550

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Completed

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

NCT00186576

Conditions: Blood and Marrow Transplant (BMT), Bone Marrow Diseases, Hematologic Diseases, +5 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details